SUN bioscience

SUN bioscience, headquartered in Lausanne, Switzerland since 2016, is a global leader in organoid hardware technology. Our flagship product, Gri3D®, offers a versatile hydrogel-based microwell platform for standardizing organoid cultures. Our innovative pipetting port enables safe medium exchange without microtissue loss in long-term 3D models and renders these cultures automatable. With multiple microwell sizes available (up to 1000 microwells in a well in a single focal plane), Gri3D® accommodates a wide range of 3D organoid models, supporting applications like patient-specific cancer therapy screening, immuno-oncology T-cell assays, gastrointestinal organoid toxicity assessment, and blood-brain barrier transport studies.